Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioHarvest Sciences Inc. - Common Stock (NQ:BHST)

7.150 -0.160 (-2.19%)
Streaming Delayed Price Updated: 12:56 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 149,999
Open 7.200
Bid (Size) 7.000 (2,000)
Ask (Size) 7.300 (100)
Prev. Close 7.310
Today's Range 6.200 - 7.480
52wk Range 4.724 - 12.80
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 10, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"... 
Via Newsfile
Topics Earnings Regulatory Compliance
BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 7, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest"... 
Via Newsfile
Topics Regulatory Compliance

Performance

YTD
+16.9%
+16.9%
1 Month
-42.8%
-42.8%
3 Month
-18.9%
-18.9%
6 Month
+8.2%
+8.2%
1 Year
+24.3%
+24.3%

More News

Read More
BioHarvest Announces Proposed Public Offering of Common Stock
Via Newsfile
Topics Regulatory Compliance
BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time
Via Newsfile
Topics Earnings
BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis
Via Newsfile
BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction
Via Newsfile
BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale
Via Newsfile
BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET
Via Newsfile
Topics Earnings
BioHarvest Sciences Reports Second Quarter 2025 Financial Results
Via Newsfile
BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time
Via Newsfile
Topics Earnings
Earnings Scheduled For August 11, 2025
Via Benzinga
BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025
Via Newsfile
BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles
Via Newsfile
BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound
Via Newsfile
Topics Artificial Intelligence
BioHarvest Sciences Reports First Quarter 2025 Financial Results
Via Newsfile
Earnings Scheduled For May 15, 2025
Via Benzinga
BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company
Via Newsfile
BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time
Via Newsfile
Topics Earnings
BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results
Via Newsfile
BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time
Via Newsfile
Topics Earnings
Earnings Scheduled For March 31, 2025
Via Benzinga
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025
Via Newsfile
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells
Via Newsfile
EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cells
Via Benzinga
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD
Via Newsfile

Frequently Asked Questions

Is BioHarvest Sciences Inc. - Common Stock publicly traded?
Yes, BioHarvest Sciences Inc. - Common Stock is publicly traded.
What exchange does BioHarvest Sciences Inc. - Common Stock trade on?
BioHarvest Sciences Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioHarvest Sciences Inc. - Common Stock?
The ticker symbol for BioHarvest Sciences Inc. - Common Stock is BHST on the Nasdaq Stock Market
What is the current price of BioHarvest Sciences Inc. - Common Stock?
The current price of BioHarvest Sciences Inc. - Common Stock is 7.150
When was BioHarvest Sciences Inc. - Common Stock last traded?
The last trade of BioHarvest Sciences Inc. - Common Stock was at 11/11/25 12:56 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.